Health Care/Hospital

Xinhua Silk Road: Why is Pien Tze Huang selected as one of China's brands favored by foreigners in 2024

BEIJING, Dec. 17, 2024 /PRNewswire/ -- Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. (Pien Tze Huang), a time-honored Chinese enterprise mainly engaging in pharmaceutical manufacturing, was selected as one of China's brands favored by foreigners in 2024 at the 2024 China Brand Day gala held i...

2024-12-17 20:40 1846

CTF Life Named Kai Tak Sports Park's Exclusive Founding Insurance Partner

Launching Community Fencing Programme to Nurture Future World-class Fencers  HONG KONG, Dec. 17, 2024 /PRNewswire/ -- Chow Tai Fook Life Insurance Company Limited (CTF Life) has become the exclusive Founding Insurance Partner of Kai Tak Sports Park (KTSP), forming strategic partnership to foster ...

2024-12-17 18:23 2013

DPC Dash - Domino's Pizza China Wins Seven-Star Award for Outstanding Contributions in Food Safety & Public Health for the Fourth Year

HONG KONG, Dec. 17, 2024 /PRNewswire/ -- DPC Dash – Domino's Pizza China ("DPC Dash" or the "Company") (1405.HK), the exclusive master franchisee for Domino's Pizza in the China Mainland, the Hong Kong Special Administrative Region ofChina , and the Macau Special Administrative Region ofChina, rec...

2024-12-17 17:57 1774

GSK Leads Global Forum in Bangkok to Address Respiratory Health Challenges

GSK hosted the third annual RespiVerse Meeting on December 13 and 14 in Bangkok, Thailand. The event brought together renowned international speakers and healthcare professionals from 17 countries to address pressing global challenges in respiratory diseases, focusing on innovative solutions and ...

2024-12-17 11:59 1650

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY® by the National Medical Products Administration of China for the Treatment of Moderately to Severely Active Ulcerative Colitis

SHANGHAI, Dec. 17, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that the National Medical Products Ad...

2024-12-17 11:48 1933

Becoming a Data-Driven Healthcare Organisation: Info-Tech Releases New Blueprint for Maximising Data Insights in a Complex Environment

As healthcare organisations confront the complexities of managing vast amounts of data, Info-Tech Research Group has published a blueprint providing IT leaders with essential strategies to overcome challenges such as data silos, compliance mandates, and cybersecurity risks. The comprehensive reso...

2024-12-17 09:59 898

Amai Proteins succesfully completed world's first human clinical trial on effects of sweet proteins, with sweelin®

REHOVOT, Israel, Dec. 17, 2024 /PRNewswire/ -- Amai Proteins , a scale-up designer of novel proteins that answer the needs of consumers and industry, has succesfullly completed world's first double-blind, random clinical trial on the effects of their ...

2024-12-17 09:00 1051

DID YOU HAVE A HIP, KNEE, OR OTHER JOINT REPLACEMENT?

If your implant/replacement involved Exactech products – including Optetrak, Optetrak Logic, Truliant, Vantage, Connexion GXL, and Equinoxe – your attention to this notice is important.  NEW YORK, Dec. 17, 2024 /PRNewswire/ -- The following is being issued by Kroll Restructuring Administration L...

2024-12-17 00:13 1091

Menarini Group announces Positive Topline Data from Pivotal Phase 3 BROADWAY & TANDEM Clinical Trials Evaluating Obicetrapib and the Fixed-Dose Combination Obicetrapib with Ezetimibe 10 mg

– Both pivotal studies achieved primary endpoints of LS mean reduction in LDL-C on top of maximally tolerated lipid-modifying therapies with high statistical significance (p<0.0001) – Approximately 50% of patients in BROADWAY (Obicetrapib monotherapy) and  over 70% of patients in TANDEM (Fixed Do...

2024-12-16 22:08 1552

World's 1st Stem Cell Book on Animals, Reveals How to Extend the Lives of Pets

KOTA KINABALU, Malaysia, Dec. 16, 2024 /PRNewswire/ -- A groundbreaking new book by Professor Dr.Mike Chan, "STEM CELLS, PEPTIDES & IMMUNOTHERAPY: Handbook on Regenerative Medicine for Animals," introduces revolutionary ...

2024-12-16 22:00 2213

Everise Expands and Diversifies Its Healthcare Services Portfolio With the Acquisition of Continuum Global Solutions' Vertical

The acquisition strengthens Everise's position as a leading end-to-end healthcare experience provider PLANTATION, Fla., Dec. 16, 2024 /PRNewswire/ -- Everise, a global healthcare customer experience leader, today announced the successful completion of its acquisition of customer experience manag...

2024-12-16 21:00 2756

Perennial General Hospital Tianjin, China's First Wholly Foreign-Owned Private Tertiary General Hospital Will Soon Commence Operations

SINGAPORE, Dec. 16, 2024 /PRNewswire/ -- Perennial Holdings Private Limited (" Perennial Holdings") is pleased to announce that Perennial General Hospital in Tianjin city ("Perennial General Hospital Tianjin"), China, has become the country's first wholly foreign-owned private tertiary general hos...

2024-12-16 19:37 2273

Meeting Baby's Nutritional Needs: Exploring How a2 Milk Powder Enhances Absorption

SHANGHAI, Dec. 16, 2024 /PRNewswire/ -- The a2® Platinum Milk Powder has been upgraded, signifying the brand's continuous innovation and progress in the field of infant nutrition. The a2®Milk Limited, a premium brand in dairy nutrition, focuses on products containing the A2 beta-casein type, anno...

2024-12-16 18:05 1207

HiRO Forges Strategic Partnership with CHA University Bundang Medical Center in South Korea

SEOUL, South Korea, Dec. 16, 2024 /PRNewswire/ -- Harvest Integrated Research Organization (HiRO), a boutique globalclinical research organization (CRO) providing cross-border clinical trial solutions, proudly announces the signing of a Memorandum of Understanding (MOU) with CHA University Bundan...

2024-12-16 10:30 1629

Take Charge of Your Health with Genuine USANA Products

SALT LAKE CITY, Dec. 16, 2024 /PRNewswire/ -- USANA Health Sciences is a leader in providing quality health supplements, foods and energy products, and skincare solutions to customers around the world. Unfortunately, counterfeit USANA products may find their way to online retailers that do not ca...

2024-12-16 08:46 1008

Innovent and Lilly Expand Collaboration Through Agreement on Commercialization Rights for Jaypirca® (pirtobrutinib) in Mainland China

SAN FRANCISCO and SUZHOU, China, Dec. 16, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic...

2024-12-16 07:55 2235

Arsana Foundation Collaborates with Om Ham Retreat & Resort to Launch Transformative 200hr Kundalini Tantra Yoga Teacher Training in 2025

BALI, Indonesia, Dec. 16, 2024 /PRNewswire/ -- Arsana Foundation  is proud to announce its partnership withOm Ham Retreat & Resort  to introduce a life-changing opportunity for individuals seeking to unlock the...

2024-12-16 07:00 2225

Bushu Pharma Applauded by Frost & Sullivan for Offering Customer Value in APAC CDMO Industry Through Consistent Quality Assurance, On-time Delivery, Sustainability, and Competitive Costs

Bushu Pharma's ongoing investments and efforts offer customers state-of-the-art capabilities, increased capacity, and innovative solutions, providing top-tier pharmaceutical manufacturing and supply chain management services. SAN ANTONIO, Dec. 15, 2024 /PRNewswire/ -- Frost & Sullivan researched ...

2024-12-15 13:30 1843

Alphamab Oncology Presented the Phase II Clinical Data of KN046 in Combination with Axitinib for the Treatment of Advanced NSCLC at ESMO IO Congress 2024

SUZHOU, China, Dec. 13, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the latest clinical data from a phase II clinical study on PD-L1/CTLA-4 bispecific antibody KN046 in combination with axitinib as first-line treatment for advanced non-small cell lung cancer (NSCLC...

2024-12-13 10:35 2186

Transcenta Debuts Promising Anti-Tumor Activity of Novel LIV-1 Targeting ADCs with Site-Specific Conjugated Topo I Inhibitor Payload in TNBC Tumor Models at 2024 SABCS

PRINCETON, N.J. and SUZHOU, China, Dec. 13, 2024 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a global clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, ann...

2024-12-13 08:00 1524
1234567 ... 575